These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34243714)

  • 1. The impact of infectious diseases consultation on the management and outcomes of Pseudomonas aeruginosa bacteraemia in adults: a retrospective cohort study.
    Chiong F; Wasef MS; Liew KC; Cowan R; Tsai D; Lee YP; Croft L; Harris O; Gwini SM; Athan E
    BMC Infect Dis; 2021 Jul; 21(1):671. PubMed ID: 34243714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: a stratified analysis according to sites of infection.
    Joo EJ; Kang CI; Ha YE; Park SY; Kang SJ; Wi YM; Lee NY; Chung DR; Peck KR; Song JH
    Infection; 2011 Aug; 39(4):309-18. PubMed ID: 21594653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia.
    Morata L; Cobos-Trigueros N; Martínez JA; Soriano A; Almela M; Marco F; Sterzik H; Núñez R; Hernández C; Mensa J
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4833-7. PubMed ID: 22751533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia.
    Cheong HS; Kang CI; Wi YM; Ko KS; Chung DR; Lee NY; Song JH; Peck KR
    Eur J Clin Microbiol Infect Dis; 2008 Dec; 27(12):1219-25. PubMed ID: 18575908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults.
    Saunderson RB; Gouliouris T; Nickerson EK; Cartwright EJ; Kidney A; Aliyu SH; Brown NM; Limmathurotsakul D; Peacock SJ; Török ME
    Clin Microbiol Infect; 2015 Aug; 21(8):779-85. PubMed ID: 26033668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study.
    Paulsson M; Granrot A; Ahl J; Tham J; Resman F; Riesbeck K; Månsson F
    Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1187-1196. PubMed ID: 28110415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality.
    Vitkauskienė A; Skrodenienė E; Dambrauskienė A; Macas A; Sakalauskas R
    Medicina (Kaunas); 2010; 46(7):490-5. PubMed ID: 20966623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of infectious diseases consultation and 30-day mortality rates among veterans with enterococcal bacteraemia: a propensity score-matched retrospective cohort study.
    Tholany J; Suzuki H; Livorsi DJ; Perencevich EN; Goto M
    Clin Microbiol Infect; 2023 Aug; 29(8):1039-1044. PubMed ID: 36914070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guideline compliance and clinical outcomes among patients with Staphylococcus aureus bacteremia with infectious diseases consultation in addition to antimicrobial stewardship-directed review.
    Buehrle K; Pisano J; Han Z; Pettit NN
    Am J Infect Control; 2017 Jul; 45(7):713-716. PubMed ID: 28431847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia.
    Robinson JO; Pozzi-Langhi S; Phillips M; Pearson JC; Christiansen KJ; Coombs GW; Murray RJ
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2421-8. PubMed ID: 22382823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is fluoroquinolone monotherapy a useful alternative treatment for Pseudomonas aeruginosa bacteraemia?
    Wu PF; Lin YT; Wang FD; Yang TC; Fung CP
    Infection; 2018 Jun; 46(3):365-373. PubMed ID: 29556979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy.
    Kim YJ; Jun YH; Kim YR; Park KG; Park YJ; Kang JY; Kim SI
    BMC Infect Dis; 2014 Mar; 14():161. PubMed ID: 24655422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Pseudomonas aeruginosa bacteraemia in a tertiary hospital: Mortality and prognostic factors.
    Callejas-Díaz A; Fernández-Pérez C; Ramos-Martínez A; Múñez-Rubio E; Sánchez-Romero I; Vargas Núñez JA
    Med Clin (Barc); 2019 Feb; 152(3):83-89. PubMed ID: 29885868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.
    Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE
    J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
    Recio R; Villa J; Viedma E; Orellana MÁ; Lora-Tamayo J; Chaves F
    Int J Antimicrob Agents; 2018 Aug; 52(2):172-179. PubMed ID: 29621591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Infectious Diseases Consultation on Clinical Outcomes of Patients with Staphylococcus aureus Bacteremia in a Community Health System.
    Turner RB; Valcarlos E; Won R; Chang E; Schwartz J
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5682-7. PubMed ID: 27401580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic therapy and clinical outcomes of Pseudomonas aeruginosa (PA) bacteraemia.
    Tan SH; Teng CB; Ng TM; Lye DC
    Ann Acad Med Singap; 2014 Nov; 43(11):526-34. PubMed ID: 25523856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Infectious Diseases Consultation on Management and Outcome of Staphylococcus aureus Bacteremia in Children.
    Duguid RC; Al Reesi M; Bartlett AW; Palasanthiran P; McMullan BJ
    J Pediatric Infect Dis Soc; 2021 May; 10(5):569-575. PubMed ID: 33355663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study.
    Bai AD; Showler A; Burry L; Steinberg M; Ricciuto DR; Fernandes T; Chiu A; Raybardhan S; Science M; Fernando E; Tomlinson G; Bell CM; Morris AM
    Clin Infect Dis; 2015 May; 60(10):1451-61. PubMed ID: 25701854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates, predictors and mortality of community-onset bloodstream infections due to Pseudomonas aeruginosa: systematic review and meta-analysis.
    Rojas A; Palacios-Baena ZR; López-Cortés LE; Rodríguez-Baño J
    Clin Microbiol Infect; 2019 Aug; 25(8):964-970. PubMed ID: 30995530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.